Cardiovascular disease and cancer share several risk factors. Patients with heart failure have a higher rate of cancer than healthy control populations. Meijers and colleagues have taken this association a step further to present new evidence suggesting that, beyond simply sharing root causes, heart failure might actually cause cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Meijers, W. C. et al. Heart stimulates tumor growth by circulating factors. Circulation 138, 678–691 (2018).
Yang, G. D. et al. SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis. Int. J. Clin. Exp. Pathol. 7, 1348–1358 (2014).
Hillege, H. L. et al. Microalbuminuria is common, also in a non-diabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J. Intern. Med. 249, 519–526 (2001).
Koene, R. J. et al. Shared risk factors in cardiovascular disease and cancer. Circulation 133, 1104–1114 (2016).
Hasin, T. et al. Patients with heart failure have an increased risk of incident cancer. J. Am. Coll. Cardiol. 62, 881–886 (2013).
Banke, A. et al. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur. J. Heart Fail. 18, 260–266 (2016).
Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
Aggarwal, B. B., Vijayalekshmi, R. V. & Sung, B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res. 15, 425–430 (2009).
Ridker, P. M. et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833–1842 (2017).
Scafidi, P., Mistelli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191–195 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Richards, A.M. Can heart failure cause cancer?. Nat Rev Cardiol 16, 7–8 (2019). https://doi.org/10.1038/s41569-018-0105-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-018-0105-x
